GKOS GLAUKOS CorpcompanySEC Filings & Insider Trading Activity 2026
Latest GLAUKOS Corp (GKOS) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 23, 2026, a 10-Q quarterly report filed on October 31, 2025, an 8-K current report filed on April 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for GLAUKOS Corp (GKOS) (SEC CIK 1192448), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business model: Development, manufacturing, and commercialization of ophthalmic surgical implants and pharmaceutical therapies
- • New product emphasis: Commercial launch of iDose TR implant in early 2024 and FDA approval plus planned commercialization of Epioxa pharmaceutical therapy in early 2026
Risk Factors
- • Regulatory risk: U.S. FDA approval of Epioxa in October 2025 requires securing permanent HCPCS J-Code and commercial payer coverage for reimbursement
- • Macroeconomic risk: U.S. tariffs on imports from Canada, Mexico, and China, despite limited exposure, risk escalating trade disputes affecting sourcing costs
Management Discussion & Analysis
- • Revenue $507.4M, up 32% YoY from $383.5M; US glaucoma sales up 50% to $298.6M, international glaucoma up 18% to $122.5M
- • Gross margin 56% in 2025 vs 75% in 2024; Operating loss $(199.6)M vs $(122.4)M; Net loss $(187.7)M vs $(146.4)M
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • New risk: MIGS restrictions by five MACs limiting iStent sales volume, impacting U.S. glaucoma product revenue growth
- • Updated operational risk: $80M+ planned capital expenditure for new Huntsville, AL R&D and manufacturing facility starting 2026
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Glaukos releasing updated investor presentation materials to be used in ongoing investor/stakeholder meetings
- • Presentation posted to investor relations site at investors.glaukos.com — signals active investor engagement period, potentially ahead of a conference or roadshow
Annual Reports Archive10-K
AI-powered analysis of GLAUKOS Corp (GKOS) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of GLAUKOS Corp (GKOS) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of GLAUKOS Corp (GKOS) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $282.9M | $314.7M | $383.5M | $507.4M |
| Gross Profit | $213.9M | $239.1M | $289.5M | $282.8M |
| Operating Income | — | -$128.7M | -$122.4M | -$199.6M |
| Net Income | — | -$134.7M | -$146.4M | -$187.7M |
| Gross Margin | 75.6% | 76.0% | 75.5% | 55.7% |
| Op. Margin | — | -40.9% | -31.9% | -39.3% |
| Net Margin | — | -42.8% | -38.2% | -37.0% |
| Balance Sheet | ||||
| Total Assets | — | $940.4M | $974.8M | $893.5M |
| Equity | — | $461.8M | $766.9M | $656.2M |
| ROE | — | -29.2% | -19.1% | -28.6% |
Source: XBRL financial data from GLAUKOS Corp (GKOS) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 29, 2026 | — | — | — |
8-K | Mar 2, 2026 | — | Analysis | — |
10-K | Feb 23, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 17, 2026 | — | — | |
8-K | Jan 13, 2026 | — | — | |
10-Q | Oct 31, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 4, 2025 | Jun 30, 2025 | — | |
10-Q | May 1, 2025 | Mar 31, 2025 | — | |
10-K | Feb 25, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 5, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 2, 2024 | Jun 30, 2024 | — | |
10-Q | May 3, 2024 | Mar 31, 2024 | — | |
10-K | Feb 23, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 1, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 2, 2023 | Jun 30, 2023 | — | |
10-Q | May 4, 2023 | Mar 31, 2023 | — | |
10-K | Feb 24, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 4, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 5, 2022 | Jun 30, 2022 | — | |
10-Q | May 5, 2022 | Mar 31, 2022 | — | |
10-K | Feb 28, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 8, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 5, 2021 | Jun 30, 2021 | — | |
10-Q | May 6, 2021 | Mar 31, 2021 | — | |
10-K | Mar 1, 2021 | Dec 31, 2020 | — |
Frequently Asked Questions
What are the latest GKOS SEC filings in 2026?
GLAUKOS Corp (GKOS) has filed a 10-K annual report on February 23, 2026, a 10-Q quarterly report on October 31, 2025, an 8-K current report on April 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did GKOS file its most recent 10-K annual report?
GLAUKOS Corp (GKOS) filed its most recent 10-K annual report on February 23, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view GKOS 10-Q quarterly reports?
GLAUKOS Corp (GKOS)'s most recent 10-Q quarterly report was filed on October 31, 2025. SignalX displays every GKOS 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has GKOS filed recently?
GLAUKOS Corp (GKOS)'s most recent 8-K was filed on April 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find GKOS insider trading activity (Form 4)?
SignalX aggregates every GKOS Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does GKOS file with the SEC?
GLAUKOS Corp (GKOS) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new GKOS filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for GLAUKOS Corp (GKOS).
What is GKOS's SEC CIK number?
GLAUKOS Corp (GKOS)'s SEC CIK (Central Index Key) number is 1192448. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1192448 to look up all GKOS filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find GKOS return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from GLAUKOS Corp (GKOS) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of GLAUKOS Corp SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 47+ filings.